OK Biotech Co., Ltd., headquartered in Taiwan (TW), is a prominent player in the biotechnology industry, specialising in innovative solutions for healthcare and life sciences. Founded in [year], the company has established itself as a leader in the development of cutting-edge biopharmaceuticals and diagnostic products, catering to both local and international markets. With a focus on research and development, OK Biotech offers a range of unique products, including advanced therapeutics and diagnostic kits that stand out for their efficacy and reliability. The company has achieved significant milestones, positioning itself as a trusted name in the biotech sector, known for its commitment to quality and innovation. Through its strategic operations across major regions, OK Biotech continues to contribute to advancements in biotechnology, enhancing patient care and outcomes globally.
How does OK Biotech Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
OK Biotech Co., Ltd.'s score of 22 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
OK Biotech Co., Ltd., headquartered in Taiwan (TW), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, OK Biotech Co., Ltd. does not have any emissions data inherited from a parent company or cascaded from a corporate family relationship. The company appears to be in the early stages of establishing its climate commitments and reduction initiatives. In the context of the biotechnology industry, it is increasingly important for companies to set measurable targets and engage in transparent reporting to align with global climate goals. Without specific emissions data or reduction strategies, OK Biotech Co., Ltd. may face challenges in demonstrating its commitment to sustainability and climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OK Biotech Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

